Bausch & Lomb under fire over fill room hygiene
This article was originally published in Clinica
Executive Summary
Flaking paint chips on a filling room ceiling is one of the complaints against eyecare manufacturer Bausch & Lomb in a recent US FDA warning letter. The letter, issued on July 17 but only released last week, notes that the company failed to take action to correct the potential contamination.